CHU de la Réunion
Saint-Denis, 97400, Reunion
NCT Number: NCT05604339
While the acute consequences of an ultratrail are beginning to be well documented, data on the study of recovery in the aftermath of an event are much rarer.
In order to overcome these various limitations, the main study of the ERUPTION-3 project is set up on the Grand Raid de La Réunion 2022 races.
In the context of exercise responses, the rheological properties of blood can impact the endurance performance. In contrast to short-distance events, the study of blood rheology and red blood cells integrity in long-distance events such as ultra-endurance races is poorly documented in the literature.
In the ancillary study, the work that is intended to be carried y out will complement the initial results found by a previous research on 23 runners during the Ultra Trail du Mont Blanc. This ancillary study will also be an opportunity to complete the data from the main study by studying the kinetics of biomarker recovery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Saint-Denis, 97400, Reunion
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 Months
Evaluate by means of subjective evaluations in the aftermath of an ultratrail run in a tropical environment:
Time frame: 3 Months
Evaluate by means of subjective evaluations in the aftermath of an ultratrail run in a tropical environment:
Time frame: 3 Months
Evaluate by means of subjective evaluations in the aftermath of an ultratrail run in a tropical environment:
Time frame: 3 Months
Evaluate by means of subjective evaluations in the aftermath of an ultratrail run in a tropical environment:
Time frame: 6 Months
Evaluate by means of subjective evaluations in the aftermath of an ultratrail run in a tropical environment:
Time frame: 1 Month
Evaluate by means of objective evaluations in the aftermath of an ultratrail run in a tropical environment:
1200m and 400m test (best race time)
Time frame: Day 2, Day 5, Day 9 and Day 16
Evaluate the changes in recovery kinetics of biological markers (hematological:haemoglobin in g/dL ) directly after the race in comparison with measurements taken before the race
Time frame: Day 2, Day 5, Day 9 and Day 16
Evaluate the changes in recovery kinetics of biological markers (muscular: Creatin PhosphoKinase in UI/L), directly after the race in comparison with measurements taken before the race
Time frame: Day 2, Day 5, Day 9 and Day 16
Evaluate the changes in recovery kinetics of biological markers (inflammatory: Protein C-reactive in mg/L) directly after the race in comparison with measurements taken before the race
Time frame: Day 2, Day 5, Day 9 and Day 16
Evaluate the changes in recovery kinetics of biological markers (hepatic: ASAT & ALAT in UI/L) directly after the race in comparison with measurements taken before the race
Time frame: Post-race (between day2 and day4 depending on the time of race arrival)
Evaluate the rheologic biomarkers by measuring the blood viscosity directly after the race in comparison with measurements taken before the race
Time frame: Post-race (between day2 and day4 depending on the time of race arrival)
Evaluate the Senescence of red blood cells directly after the race in comparison to before the race, by taking blood samples and analysing them using spectrophotometry and fluorescent-activated cells sorting
Centre Hospitalier Universitaire de la Réunion
Other
Etude de la récupération et Des Modifications de la rhéologie Sanguine Chez Les Coureurs d'Ultraendurance ERUPTION-3 / Study of Recovery and Blood Rheology Changes in Ultra-endurance Runners ERUPTION-3
Acronym: ERUPTION-3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02839070
Physiology
Boston, Massachusetts, United States
View Trial DetailsNCT02850367
Physiology
Grenoble, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT01154582
Behavior, Behavior, Animal
Bobigny, France
View Trial DetailsNCT05168501
Pathologic Processes, Pathological Conditions, Signs and Symptoms
West Bend, Wisconsin, United States
View Trial Details